Stockhead on MSN

Neurotech’s NTI164 shows strong long-term safety in 90-day canine toxicology study

Neurotech International has announced positive results from a 90-day repeat-dose oral toxicity canine study of its lead drug ...
FiercePharma

Neurotech's vision loss cell therapy implant hits primary goals in phase 3 trials

A pair of phase 3 trials of Neurotech Pharmaceuticals’ encapsulated cell therapy implant have met their primary endpoints, positioning the biotech to talk to the FDA about bringing the treatment for a ...

Neurotech partners with University of Sydney to advance Rett syndrome program

Neurotech International has entered a research collaboration with the University of Sydney to advance its proprietary ...
Fast Company

With neurotech, control over our minds is less absolute than we think

Socrates, the ancient Greek philosopher, never wrote things down. He warned that writing undermines memory—that it is nothing but a reminder of some previous thought. Compared to people who discuss ...
FierceBiotech

AI-powered neurotech developer Elemind emerges from stealth with backing from Bezos, Gates

It’s electric! A startup emerged from stealth this week with grand plans to pioneer a new form of neurotech dubbed “electric medicine.” Elemind’s approach centers on artificial intelligence-powered ...